Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
TODAY, THE DETAILS of the government’s National Covid-19 Vaccination Programme were announced.
With the first vaccines set to be available soon – as early as before the end of this year according to Health Minister Stephen Donnelly – the strategy delves into the logistics and planning that will be required for large swathes of the country to be innoculated against Covid-19.
The plan also includes details on where people will be vaccinated, the process of arranging an appointment to get a vaccine and the systems that will be needed to monitor its rollout.
The plan says: “The objective of the vaccination programme is, in the first instance, to reduce mortality anod morbidity as a consequence of Covid-19.
In addition, successful deployment of safe and effective Covid-19 vaccine(s) will be a more sustainable long-term public health measure, over time allowing society to re-open more fully, our communities to reconnect in the ways we used to take for granted and for our economy to resume a positive growth trajectory.
The focus at the start of the vaccination programme will be on adults over the age of 65 who are residents of long-term care facilities and frontline healthcare workers in direct patient contact roles, including vaccinators.
Those aged 70 and older will be next, starting with over 85s.
There’ll be three phases of rollout of the vaccines.
The initial rollout phase will see limited doses available. This will begin late this year or early next year.
Minister Donnelly said today: “If the European Medicines Agency meet on the 21st of December and if they conclude on a positive on the Pfizer vaccine, it would likely be several more days, potentially the 23rd of December, before the formal authorisation would be given by the EMA.
“It would then take a number of days, potentially up to a week for initial vaccination here. But it is important to stress that this would be an initial delivery, it would at a very low volume. We’re not looking at widespread vaccination but it would be very encouraging if it did happen to even see the programme of vaccination commence before the end of the year.”
Once a larger number of doses become available, the mass ramp-up phase will begin with larger cohorts of people receiving the vaccine.
It is not yet known when this phase could begin, and depends on the “vaccine delivery schedule”, according to the plan. It’s likely this may not happen until the second quarter of 2021 at the earliest.
The last phase is called open access, where the remaining people who’ve yet to receive the vaccine are then eligible.
Where will we get it?
There are a variety of locations where a person may receive the vaccine, including mass vaccination centres that are set to be created around the country.
A section of the plan delves into managing the supply, storage and distribution of Covid-19 vaccines.
The end-to-end supply chain plan will start with supply from manufacturers, through to central storage, the preparation for distribution, delivery logistics and, finally, to the vaccination location.
The plan says: “Initially, Covid-19 community vaccination teams will be deployed to administer vaccines to the residents and staff of Long-Term Care Facilities. To date, we have identified a number of large scale healthcare sites that will be used as hubs for mobile vaccination teams to collect vaccines prior to vaccinating in Long-Term Care Facilities.”
During the initial rollout phase, the vaccine will be administered in long-term care facilities and large scale healthcare sites.
Once we reach the mass ramp-up phase – when large numbers will begin to receive a vaccine – vaccination will also be done in mass vaccination centres, as well as GPs and pharmacies.
Examples of vaccination administration locations include acute hospitals such as Tallaght Hospital, St James’s and Beaumont (all Dublin), as well as Mayo General Hospital, Cavan General Hospital, Cork University Hospital and University Hospital Galway.
Vaccines will also be administered in community nursing units around the country.
Examples of the sites for mass vaccination centres are Citywest and the National Exhibition Centre in Cloghran.
Colleges have also been mooted as a location for mass vaccination centres.
Chair of the high-level vaccine task force Professor Brian MacCraith said today he has had discussions with a number of third-level institutions about using their campuses to develop mass vaccination centres, and that the HSE were “working on that” idea.
“I’ve spoken with the presidents of NUI Galway, Waterford IT, University of Limerick, and UCC in the past number of days, and all have expressed great support for the concept of actually being able to assist in the development of mass vaccination centres.”
The plan adds: “These centres will be located regionally and designed to cater for large numbers of recipients in an efficient and timely manner. Discussions are underway with the relevant authorities to ensure that a geographical distribution of such mass vaccination centres is provided.”
What’ll happen when we go to get it
As explained above, a prioritisation list for who gets the vaccine will mean people get it at different times.
For example, people aged 65-69 are listed as the fifth cohort for who’ll receive the vaccine.
Advertisement
When it is your turn, you will be invited to register, provide some medical and personal details and consent to vaccination. People will be offered scheduled appointments to attend a named location for vaccination.
On the day of the appointment, pre-registered details will be confirmed on arrival.
When the person goes in to get their vaccination jab, the person administering the vaccine will confirm their details, complete informed consent and record their own details as well as batch details and a time/date stamp.
The vaccinator will then prepare the dose and administer the vaccine.
After this the patient will be asked to wait for 15 minutes to monitor for any immediate adverse reactions. Trained clinical staff will need to be on hand to observe the patients.
Aftercare will involve follow-up reminders to ensure people return for their second dose.
The strategy states the goal is to “provide a consistent process with a common data and technology platform, across all clinical settings in which the vaccine is administered”.
If there are any suspected side effects in the days or weeks afterwards, the recipient will be able to report this on a portal on the Health Products Regulatory Authority (HPRA) website and through their GP.
Who’ll be administering the vaccines?
All vaccinators will be qualified and registered healthcare professionals.
Vaccinators may include:
Medical and nursing staff in the acute hospital system
Medical and nursing staff in the community healthcare system
Medical and nursing staff in private hospitals and healthcare facilities
General Practitioners
Other regulated healthcare professionals approved to vaccinate
As more doses of vaccines becomes available during 2021, the government noted in its plans today that there will be a need to expand the pool of skilled workforce to administer vaccines and to deliver the programme.
Currently, a number of options are being explored to support the scaling up of the workforce for the programme and discussions will be taking place with respective staff groups and bodies over the coming weeks, the plan outlines.
The government is considering actions being taken by other jurisdictions, such as the licensing of recently retired health professionals or maintaining registration in the case of others.
PA Images
PA Images
The plan noted that GPs and pharmacists can and have successfully delivered significant numbers of flu vaccines. Subject to agreement, they will be able to offer enhanced capacity for the programme.
Pharmacists, however, may need to be specifically licensed for Covid-19 vaccinations.
The vaccination programme will also require significant increases in the number of administrative and support staff. In this regard, there may be opportunities to leverage the broader public service to achieve this.
All staff working in the Covid-19 vaccination programme will receive training relevant to their role in the team and service.
Training programmes will be delivered online, and where required, in person.
Along with the specialist clinical training required for vaccinator staff, induction and orientation training will be given to all staff working in vaccination centres and as part of Covid-19 community vaccination teams.
This will include, but is not limited to, training in infection prevention control and in relation to the technology solutions which support the vaccination process.
Standard operating procedures will be developed for the vaccination centres and teams. These procedures will outline all required processes to support the vaccination pathway.
How will health authorities monitor all of this?
A new IT system is at the heart of the plan for the rollout of vaccines in Ireland.
Ireland’s healthcare IT systems don’t have the right functions needed to cope with the scale of the Covid-19 vaccine rollout, which means a system must be created from scratch and integrated with the HSE’s systems.
IBM and software giant Salesforce have been tasked with creating the system.
It will allow for the planning and scheduling of vaccines and will monitor the success and effectiveness of the programme.
A functionally rich and proven solution for the proposed vaccination programme must be sourced, purchased, implemented and integrated into the HSE ICT infrastructure before the end of the year.
HSE CEO Paul Reid Leon Farrell / Rollingnews.ie
Leon Farrell / Rollingnews.ie / Rollingnews.ie
“It’s an off the shelf CRM [Customer relationship management] system… We widely expect the IT system will be available,” HSE CEO Paul Reid said at a press conference this afternoon, adding that if it wasn’t ready in time for the rollout of the vaccine, they have a backup plan.
Across the IT infrastructure, it will track important elements related to pre-vaccination and vaccine administration.
As regards data processing, the HSE is liasing with the Data Protection Commissioner on the matter. How the system will impact on personal data, and an individual’s privacy and confidentiality will be the subject of a Data Protection Impact Assessment.
What’s all this about ‘individual health identifiers’?
An Individual Health Identifier (IHI) is a number that identifies each person within the public and private health sector in Ireland, a unique number that is different to a PPSN.
They were first proposed by government in 2015, with patient safety cited as a key advantage of an IHI. Although planning for IHIs have been in the works for some years no, they haven’t been formally rolled out as of yet.
Related Reads
Here's what'll happen when you go to get your Covid-19 vaccine
Rollout plan: First vaccines possible by end of year, universities could be used as mass vaccination centres
“Being able to uniquely identify each user will improve patient safety by reducing the number of adverse events that may happen, such as giving the patient incorrect medication or vaccinations or admitting the wrong person for surgery,” HIQA said, in its guidance on IHIs.
The commenced order for IHIs was signed in 2017, although work on implementing them across national healthcare systems has not yet been completed.
As part of the government’s vaccination implementation plan, the first step is enabling public registration and facilitating the booking of an appointment to receive the vaccination.
“Utilisation of the IHI is critically important as it will ensure that each person is uniquely identified for full traceability of the individual,” the plan states.
The identifying patient number would allow electronic recording of every individual vaccination. No medical information is stored on the health identifier record but is instead used by health service providers when they are communicating on your behalf.
“Being able to uniquely identify each user will improve patient safety by reducing the number of adverse events that may happen, such as giving the patient incorrect medication or vaccinations or admitting the wrong person for surgery,” according to Hiqa.
Under the Health Identifiers Act 2014, IHIs are considered to be personal data and are protected as such.
Serving as a patient identifier number, the IHI will be used in conjunction with the new vaccination IT system.
The requirements for GPs and pharmacies in this regard have not yet been defined. The report adds that the national solution will have to ensure that systems from GPs and pharmacies can be integrated as part of the overall plans.
A HSE spokesperson added: “People will, when registering for the vaccine, be provided with an Individual Health Identifier (IHI), a Data Protection Impact Assessment is being developed by the HSE. The HSE has and will continue to engage with the DPC to seek their guidance and advice to ensure we comply fully with the regulations.”
What about the different vaccines?
The European Medicines Agency (EMA) today brought forward its possible approval of the Pfizer/BioNTech coronavirus vaccine by a week to 21 December.
Announcing the vaccine strategy this afternoon, Minister Donnelly said vaccines will begin to be administered in Ireland within a week of this approval, opening the possibility of the process getting underway before the end of the year.
Donnelly stressed that this is conditional on the EMA validating the vaccine.
Vaccine taskforce chief, Prof Brian MacCraith, said following the approval it is expected to take 7-10 days for the first doses of Ireland’s allocated 2.2 million Pfizer/BioNTech vaccines to be delivered. However, the delivery schedule has yet to be finalised.
“We can’t be explicit at this stage. I suppose, it appears that it could happen before the end of the year,” Prof MacCraith said.
The EMA is set to make its recommendation on the Moderna vaccine on 12 January and delivery is expected within 10 days of the decision. Ireland has been allocated 880,000 doses of the American company’s jab.
The Astrazeneca vaccine is another promising candidate and is expected to be available in January 2021 at the very earliest. Ireland has around 3.3 million doses of this vaccine ordered.
Ireland also has 2.475 million doses of a vaccine manufactured by Curevac ordered, with its earliest approval date in February 2021.
Another 5.5 million vaccines have been ordered of those in development by Sanofi/GSK and Janssen, but these aren’t expected to be available until at least the middle of next year.
As it stands, the first vaccine to be administered in Ireland is almost certainly set to be the one developed by Pfizer/BioNTech.
How will the government and health authorities communicate all of this?
A key part of the strategy centres on clear, transparent communication with the public around the vaccine rollout, its efficacy and any concerns that are raised.
The communications strategy will have two main phases.
The plan says: “The first is preparing for the vaccine, talking to the safety and regulatory processes that are taking place in Ireland, Europe and across the world, engaging with people who have genuine hesitancies around the vaccine, communicating the Government Plan from acquisition to prioritisation to distribution and talking to the results of the clinical trials when they are available.
The second phase will focus on the execution of the vaccine – national and local communication from medics encouraging the public to get the vaccine, informing who will administer it and where, identifying people of trust to act as ambassadors for the vaccine.
As part of the approach to building confidence, public health doctors will address misinformation which appears on social media and across the dark web, pointing people to trusted sources of information including gov.ie and hse.ie.
At all times the communications plan will aim to have a clear and consistent communication to encourage vaccine uptake.
NPHET will also also monitor vaccine uptake and provide regular updates on this progress.
Amid the positivity of today’s announcement, chief medical officer Dr Tony Holohan emphasised that just because vaccines are on the way, it doesn’t mean we can let our guard down.
He said: “We know we’re not through this yet. The virus doesn’t care that we’ve done well recently relative to other countries, it doesn’t care that we’re all tired, or desperate to see family and friends, and it doesn’t care that a vaccine is on the horizon.”
Dr Holohan also said the virus was “no different” in terms of the danger it poses to people who become infected than it was last March.
“The vaccine won’t have a positive effect on the trajectory of this disease for at least months to come,” he warned.
With reporting from Gráinne Ní Aodha, Daragh Brophy, Christina Finn, Michelle Hennessy, Hayley Halpin, Ceimin Burke and Adam Daly
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
TheJournal.ie's Coronavirus Newsletter
TheJournal.ie's coronavirus newsletter cuts through the misinformation and noise with the clear facts you need to make informed choices. Sign up here
To embed this post, copy the code below on your site
Close
67 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic.
Please familiarise yourself with our comments policy
here
before taking part.
@Fergal O’Hagan: Good news for some but vaccinating children against a virus that has little or no effect in them is just plain wrong.
I honestly can’t believe the government are proposing this. My hope is that by then the virus will be contained to a point where the government don’t feel this is a necessary action.
My children will 100% not be getting this vaccine just for the sake of others. I’m sorry but as a parent I have to draw the line somewhere.
@Jim Smith: According to the data on the chart, children and pregnant women will only get the vaccine if they are referred. In other words, unless the vaccine is essential to their health because of an underlying health condition, then children will not be vaccinated. Most children show few symptoms so they don’t need it.
@Ann Reddin: Thanks so much for sharing that information. It’s good to know that there isn’t a plan in place to vaccinate perfectly healthy children.
The government pushing the children’s flu vaccine was very disturbing. I actually got a call from my GP asking what day I wanted to book my kids in for the nasal vaccine. Needless to say I never asked for this.
@Barry Somers: People like myself? What are you on about? You’re trying to put me in a neat little package as an antivaxxer, conspiracy theorist. It’s getting really boring.
My kids have been vaccinated for illnesses that could potentially harm them. I will not vaccinate them for a virus that causes them little to no harm.
@Jim Smith: so we’re your children vaccinated as babies, have they had booster shots through the years, if parents all had same attitude when measles and polio vaccination started you and your children would not have going up in a country almost free of these crual illnesses, I had a young cousin who died of polio, i had an aunt who spent years in a hospital with TB children still die of measles if not vaccinated or can get very sick everyday here for months we’ve had the fb scientists telling us how schools are spreading it calls to close the schools now the exact same people are shouting “not vaccinating my child so you want cake and eat it
@nelliekel: Sorry to hear about those who died. Illnesses like polio, measles and mumps are very dangerous for children and thankfully we have vaccines. However, there are very important differences here.
1. Covid poses little or no risk to healthy children so a vaccine is not necessary for them.
2. By giving a child a vaccine for an illness like Covid you are disrupting the body’s natural process of developing the immune system to help fight future infections. This is why we don’t give children the flu vaccine every year.
3. (Most importantly)This vaccine hasn’t been fully tested for long term side effects so there’s more risk to them with the vaccine than without it.
Will people be able to defer or reject the Vaccine I wonder, I dont plan on getting it until Phase 3 trials are completely finished, who knows if this Vaccine has long term side effects yet…
@Adam J: it’s not mandatory so you can wait or refuse it altogether. Though I wouldn’t go planning a holiday abroad because airlines are already talking about requiring passengers to be vaccinated
@Paul Furey: Come out from under your rock. You do know nurses who deal with elderly patients every year in our hospitals have less than 50% take up of the flu vaccine.
@Owen Martin: Some people are legitimately unable to get it, be it because of allergies or severely compromised immune symptoms, so they’d still be relying on others to get the vaccine to keep them safe
@Anon.me:Pfizer Covid-19 vaccine prevents symptomatic cases of the virus, but it’s not clear if the shot keeps the disease from being transmitted, U.S. Food and Drug Administration staff found in a report issued. So we still continued use of public-health measures including masks and social distancing, even among those who have been immunized.
@Giovanni Giusti: bit annoying that i may have to wait until early spring/late summer for vaccine. This year was a bad year and hoped that would be vaccinated early in the year.
@Giovanni Giusti: hopefully as other people are getting vaccinated your chances of catching it keep getting slimmer. I’ve no idea where I will end up on the list as I’ve had covid and I’m not in an at risk category but I just can’t wait for us to be out of it and back to normal
@Seán Gordon: Except not all elderly can be vaccinated due to history of allergies etc. Also some patients might not mount sufficient immune response to the vaccine, so they will still be at risk from those who have not been vaccinated.
Good god! Another IT system that’ll most likely end up costing the country millions, again! Or have a ton of bugs that’ll constantly need “paid maintenance work” carried out on it! They couldn’t organise a p-up in a brewery!!
Listening to some of the interviews about this on the radio, the reason for the delay was placed on the development of the IT system to monitor the rollout.
The article says first that it is being created from scratch to be integrated into the HSE system by IBM and Sales force.
Yet a couple of paragraphs later Paul Reid, the HSE chief, says that it is an off the shelf CRM system.
It can hardly be both.
@Jim Buckley Barrett:
Maybe so Jim, but the initial impression that was being circulated was that this was going to be a stand alone system, created from scratch, for the HSE.
Now we are told that it’s an off the shelf system from a global giant.
What access will the supplier or others apart from the HSE, have to information in the system when it’s implemented.
Is the same system being integrated into the IT systems of other countries where the vaccine is being rolled out.
Are we going to be told in a short while that the information in the system will be shared to provide people with a vaccine passport.
Today’s roadshow has been interesting, but seems to have created more questions than answers.
@Garry Coll: This is the HSE if you expect a smooth run out of the vaccine. Kudos. I really admire your optimism their ability to make a balls of things is legendary. We have been listening since March about this vaccine how or when it would be available was sketchy at the time. But we all knew it was coming sometime. So why aren’t they better prepared. They should be ready to roll ASAP. It was the same with Donnelly tonight on 6 news saying it was a great news day for everyone. Yet 1st question about roll out “don’t know” 2nd possibly 3rd maybe. Prevarication as usual. I’ll stick to my mask,hand washing and S.Distancing better chance of that keeping me safe!
I’m high risk due to a degenerative neurological illness. I will not consider taking a vaccine until stage 3 trials have finished and the full data has been published, otherwise I’m making an uninformed choice which I’m not prepared to do. I know doctors who spread false information cos it suits them. Leo is another Dr that deceives and manipulates, I would never trust the hse or the pharma companies. I am not anti vax, I am anti corruption. There is no certainty that the vax will not make my illness worse, so I will wait.
@Tony Ember: I think Stage 3 is finished.
This is now stage 3.
It’s correct that they have not tested it on every type of condition so there is still an adverse risk for some.
More information and monitoring needed.
In general I don’t think there is much concern but like everything there’s always a risk of adverse reaction even if rare.
The 22,000 in stage 3 will be exceeded in hours of the Rollout and I’d imagine a large amount of data and information will become more available as it proceeds.
@Michael Flynn: i think I heard it said on the news by the head of the HSE Paul Reid, that the type of vaccine you get may depend on your age, health etc.
@Jane Alford: Calm down Jane, GP’s and Pharmacists are going to be involved in the roll out. Unless you like on a raft in the Atlantic Ocean you’ll be fine.
@Fred the Muss…: G.P’s and pharmacies can’t administer Pfizer vac without proper freezer storage. This I was told today by my G.P they will only be used for the others Oxford or Moderna excuse me if I didnt get names exactly right.
Over €13m spent by OPW on controversial Cork flood defence scheme before construction begins
Conor O'Carroll
3 hrs ago
1.3k
9
Knock airport
Fresh appeal for information after cyclist dies from injuries sustained in hit and run
4 hrs ago
6.0k
Courts
Three men jailed for 'cruel and depraved' rape of woman they encountered in Dublin nightclub
14 hrs ago
45.7k
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 160 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 110 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 142 partners can use this purpose
Use limited data to select advertising 112 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 133 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 59 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 37 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 92 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 99 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 88 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 69 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say